Avedro lands $25 mln

Avedro Inc, an ophthalmic pharmaceutical and medical device company, has secured $25 million in financing. Lilly Asia Ventures led the round with participation from return backers OrbiMed Advisors, InterWest Partners and HealthQuest Capital.

2 May 2018•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail